Potential vaccine treats and prevents deadly streptococcal toxic shock

Griffith Enterprise
Published
A new vaccine developed by Griffith University Institute for Glycomics researchers has the potential to treat and prevent toxic shock caused by invasive streptococcal disease, which kills more than 160,000 people every year. “Streptococcal toxic shock syndrome is an acute condition like meningococcus – if you get exposed to the organism you can be dead […]

Teamwork leads to excellent results

Griffith Sciences
Published
When Professor Michael Good first arrived at Griffith University seven years ago he never imagined that a vaccine to protect against the nasty Streptococcus A infection would already be at pharmaceutical development stage. But with the support of Vice Chancellor Ian O’Connor, Institute for Glycomics Director Professor Mark von Itzstein and a remarkable research team […]